Cargando…
B‐cell haematological malignancies and SARS‐CoV‐2 infection: Could immunological interventions influence the outcome?
B cell haematological malignancies (HMs) have been described as the worst cancer type for concomitant COVID‐19 in terms of mortality, with rates up to 65%. This risk factor for COVID‐19 cannot only be explained by comorbidities and advanced age of patients, but aggravated by secondary immunodeficien...
Autores principales: | Ochoa‐Grullón, Juliana, Peña Cortijo, Ascensión, Guevara‐Hoyer, Kissy, Jiménez García, Carlos, de la Fuente, Eduardo, de la Peña, Antonia Rodríguez, Fernández‐Arquero, Miguel, González Fernández, Ata, Sánchez‐Ramón, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426868/ https://www.ncbi.nlm.nih.gov/pubmed/34518828 http://dx.doi.org/10.1002/jha2.249 |
Ejemplares similares
-
Trained Immunity-Based Vaccine in B Cell Hematological Malignancies With Recurrent Infections: A New Therapeutic Approach
por: Ochoa-Grullón, Juliana, et al.
Publicado: (2021) -
Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2020) -
Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement
por: de la Fuente-Munoz, Eduardo, et al.
Publicado: (2022) -
Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression
por: Ochoa-Grullón, Juliana, et al.
Publicado: (2022) -
Trained Immunity Based-Vaccines as a Prophylactic Strategy in Common Variable Immunodeficiency. A Proof of Concept Study
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2020)